Fox Run Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-740
Closed -$329K 698
2023
Q3
$329K Buy
+740
New +$334K 0.1% 405
2023
Q1
Sell
-574
Closed -$232K 628
2022
Q4
$232K Buy
+574
New +$269K 0.09% 437

Other funds holding AGL

Fox Run Management's AGL Position: Q4 2023 in Review

Fox Run Management sold out of Agilon Health (AGL) in Q4 2023, closing a stake of 740 shares — an estimated $329K sold.

Fox Run Management first reported a position in AGL in Q4 2022 and held it in 2 quarters. The position peaked at $329K in Q3 2023. 193 funds tracked by Wall St. Rank hold AGL as of Q4 2023.

  • Fox Run Management reported no remaining Agilon Health position as of Q4 2023 after selling out during the quarter.
  • Fox Run Management sold 740 Agilon Health shares in Q4 2023, an estimated $329K.
  • Fox Run Management first reported a position in Agilon Health in Q4 2022 and held it in 2 quarters.
  • Fox Run Management's Agilon Health position peaked at $329K in Q3 2023.
  • 193 funds tracked by Wall St. Rank held Agilon Health as of Q4 2023.

Based on Fox Run Management's 13F filing for Q4 2023, filed 13 Feb 2024.